Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Thill

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast CancerUlrike A Nitz, Oleg Gluz, Sherko Kümmel, et al.
NPJ Breast Cancer|September 29, 2025
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancerJustin M Balko, Luca Licata, Xiao Qian Wang, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 1 - Prevention and Early StagesElmar Stickeler, Bahriye Aktas, Annika Behrens, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and BiomarkersNina Ditsch, Elmar Stickeler, Annika Behrens, et al.
Nature|September 6, 2023
Spatial predictors of immunotherapy response in triple-negative breast cancerXiao Qian Wang, Esther Danenberg, Chiun-Sheng Huang, et al.
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast CancerManfred Welslau, Volkmar Müller, Diana Lüftner, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast CancerRachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast CancerMatteo Dugo, Chiun-Sheng Huang, Daniel Egle, et al.
Annals of Surgical Oncology|November 10, 2023
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New ConceptAndré Pfob, Lie Cai, Andreas Schneeweiss, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2022
Endocrine Therapy Response and 21-Gene Expression Assay for Therapy Guidance in HR+/HER2- Early Breast CancerUlrike A Nitz, Oleg Gluz, Sherko Kümmel, et al.
NPJ Breast Cancer|September 29, 2025
Tumor-specific major histocompatibility-II expression predicts pathological complete response to atezolizumab combined to chemotherapy in triple-negative breast cancerJustin M Balko, Luca Licata, Xiao Qian Wang, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 1 - Prevention and Early StagesElmar Stickeler, Bahriye Aktas, Annika Behrens, et al.
Geburtshilfe Und Frauenheilkunde|May 26, 2021
Update Breast Cancer 2021 Part 2 - Advanced Stages, Long-Term Consequences and BiomarkersNina Ditsch, Elmar Stickeler, Annika Behrens, et al.
Nature|September 6, 2023
Spatial predictors of immunotherapy response in triple-negative breast cancerXiao Qian Wang, Esther Danenberg, Chiun-Sheng Huang, et al.
Geburtshilfe Und Frauenheilkunde|July 29, 2022
Update Breast Cancer 2022 Part 1 - Early Stage Breast CancerManfred Welslau, Volkmar Müller, Diana Lüftner, et al.
Breast (Edinburgh, Scotland)|April 5, 2025
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBCElena Laakmann, Marcus Schmidt, Kristina Lübbe, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Update Breast Cancer 2024 Part 1 - Expert Opinion on Advanced Breast CancerRachel Würstlein, Hans-Christian Kolberg, Andreas D Hartkopf, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 23, 2024
The Immune-Related 27-Gene Signature DetermaIO Predicts Response to Neoadjuvant Atezolizumab plus Chemotherapy in Triple-Negative Breast CancerMatteo Dugo, Chiun-Sheng Huang, Daniel Egle, et al.
Annals of Surgical Oncology|November 10, 2023
Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New ConceptAndré Pfob, Lie Cai, Andreas Schneeweiss, et al.
Pageof 17